Hispanic and Latino (HL) cancer survivors are at a critical disadvantage compared with non-
Hispanic White (NHW) patients regarding sociodemographic adversities and access to …

Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and
affects patients of all genders, races, ethnicities, and socioeconomic status. While the …

Background Liver cancer is ranked fifth in incidence and second in mortality among cancers
in Taiwan. Nevertheless, the Taiwan government does not screen for liver cancer in its free …

Abstract Background and Objectives Early detection of hepatocellular carcinoma (HCC) is
associated with improved survival. However, a greater proportion of patients treated at safety …

Background Neoadjuvant chemotherapy (NAC) is standard management for localized
gastric cancer (GC). Attrition during NAC due to treatment‐related toxicity or functional …

Hepatocellular carcinoma (HCC) is the most commonly diagnosed liver malignancy and is
primarily caused by alcohol-induced liver disease or hepatitis C infection. 1 The screening of …

Abstract Background The coronavirus (COVID‐19) pandemic led to disruptions in operative
and hospital capabilities as the country triaged resources and canceled elective procedures …

There are significant ethnic disparities in incidence, tumor stage, curative therapy receipt,
and survival among patients with hepatocellular carcinoma (HCC) in the US. While previous …

Stress is an important factor in disease risk and health outcomes; stress responses are now
included in conceptual models of minority health and health disparities. This chapter reviews …

Background: The ECOG performance status (PS) scale was developed to support national
clinical trials, but the degree to which ECOG PS predicts clinical outcomes in patient …